DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 190 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,533,528 | -48.9% | 171,532 | -55.3% | 0.01% | -50.0% |
Q2 2023 | $4,954,742 | +30.9% | 383,494 | -0.6% | 0.02% | +22.2% |
Q1 2023 | $3,784,011 | -6.9% | 385,730 | +1.0% | 0.02% | -18.2% |
Q4 2022 | $4,063,065 | +1.9% | 381,867 | -0.0% | 0.02% | -8.3% |
Q3 2022 | $3,989,000 | -14.4% | 382,050 | +3.3% | 0.02% | -11.1% |
Q2 2022 | $4,658,000 | +16.2% | 369,953 | 0.0% | 0.03% | +35.0% |
Q1 2022 | $4,010,000 | -22.7% | 369,953 | +0.4% | 0.02% | -20.0% |
Q4 2021 | $5,185,000 | -24.8% | 368,540 | +2.7% | 0.02% | -32.4% |
Q3 2021 | $6,893,000 | +50.8% | 358,830 | -22.7% | 0.04% | +48.0% |
Q2 2021 | $4,570,000 | +0.2% | 463,980 | -0.0% | 0.02% | -7.4% |
Q1 2021 | $4,563,000 | +297.5% | 464,198 | +80.0% | 0.03% | +285.7% |
Q4 2020 | $1,148,000 | +51.1% | 257,909 | +46.6% | 0.01% | +40.0% |
Q3 2020 | $760,000 | +523.0% | 175,875 | +1173.8% | 0.01% | +400.0% |
Q2 2020 | $122,000 | +320.7% | 13,807 | +66.0% | 0.00% | – |
Q1 2020 | $29,000 | +70.6% | 8,318 | +176.6% | 0.00% | – |
Q4 2019 | $17,000 | +54.5% | 3,007 | 0.0% | 0.00% | – |
Q3 2019 | $11,000 | -8.3% | 3,007 | 0.0% | 0.00% | – |
Q2 2019 | $12,000 | -69.2% | 3,007 | -43.1% | 0.00% | – |
Q1 2019 | $39,000 | -18.8% | 5,287 | 0.0% | 0.00% | – |
Q4 2018 | $48,000 | -27.3% | 5,287 | 0.0% | 0.00% | -100.0% |
Q3 2018 | $66,000 | -7.0% | 5,287 | +13.5% | 0.00% | 0.0% |
Q2 2018 | $71,000 | -22.8% | 4,657 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $92,000 | -40.3% | 4,657 | -43.6% | 0.00% | 0.0% |
Q4 2017 | $154,000 | +0.7% | 8,257 | +16.0% | 0.00% | 0.0% |
Q3 2017 | $153,000 | +1175.0% | 7,120 | +474.2% | 0.00% | – |
Q2 2017 | $12,000 | -74.5% | 1,240 | -84.3% | 0.00% | – |
Q1 2017 | $47,000 | +123.8% | 7,920 | +45.6% | 0.00% | – |
Q4 2016 | $21,000 | -63.2% | 5,440 | 0.0% | 0.00% | -100.0% |
Q3 2016 | $57,000 | +375.0% | 5,440 | +535.5% | 0.00% | – |
Q2 2016 | $12,000 | -25.0% | 856 | 0.0% | 0.00% | – |
Q1 2016 | $16,000 | -23.8% | 856 | 0.0% | 0.00% | – |
Q4 2015 | $21,000 | +110.0% | 856 | +120.6% | 0.00% | – |
Q3 2015 | $10,000 | – | 388 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |